$2.01B in Funding Deals and 71 Companies Added

CipherBio Weekly Digest: Week of Feb 17 – Feb 23, 2022

$2.01B
Deals

$274.03M
Series A 

71
New Companies on CipherBio

 

Top Deals This Week

Minded, New York-based digital health/AI company, raises $25M in Seed round from various investors. Plexium raises $102M in Series A led by BVF Partners, L.P. and TCG X. Equip Health raises $58M in Series B led by The Chernin Group. In Series E  Somatus raises $325M led by Wellington Management. Sirona Medical acquires Nines for an undisclosed amount.

See Investors Insights ➜
Company Round Amount
Minded Seed $25M
Plexium Series A $102M
Equip Health Series B $58M
Somatus Series E $325M
Nines Acquisition Undisclosed

 

This Week in Clinical Phases

NovelMed announces phase 1 clinical trial of NM8074. In phase 2 Evelo Biosciences announces trial of EDP1815 in Atopic Dermatitis. Belgium-based Pharmazz announces phase 3 clinical trial of Sovateltide for ischemic stroke. Senseonics announces FDA approval of Eversense E3 CGM System.

 

See All Clinical Insights ➜
Company Product and Clinical Phase Indications
NovelMed NM8074Phase 1 Paroxysmal Nocturnal Hemoglobinuria (PNH)
Evelo Biosciences EDP1815, Phase 2 Atopic Dermatitis, Allergic Diseases
Pharmazz Sovateltide, Phase 3 Ischemic Stroke
Senseonics Pure-Vu® EVS System, FDA Cleared Diabetes

 

71 Life Science Companies Added

This week we added 71 life science companies to our platform.

9 of 71  New Companies
See Companies Insights ➜
Hyphen Semaai NovelMed
Ageless Biotech TargED Biopharmaceuticals High Tide Therapeutics
MediBuddy Heyy ProJenX

 

To get all the latest life science deals and VC funding data delivered straight to your inbox weekly become a CipherBio PRO member.

Get CipherBio PRO Account

Request Your PRO Demo